Results 1 to 10 of about 584,998 (146)
Idiopathic Multicentric Castleman Disease Associated With Seronegative Erosive Chronic Polyarthritis: A Diagnostic Challenge [PDF]
ABSTRACT Idiopathic multicentric Castleman disease can rarely present with systemic inflammation and erosive seronegative polyarthritis. Awareness of this association helps prevent misdiagnosis and ensures appropriate immunosuppressive management based on clinicopathological and immunohistochemical correlation.
Lo B +9 more
europepmc +2 more sources
Idiopathic Multicentric Castleman Disease With Severe Eosinophilia and Diffuse Centrilobular Nodule-A Rare Case Report. [PDF]
Rationale Idiopathic multicentric Castleman disease (iMCD), also known as angiofollicular lymph node hyperplasia, is a rare inflammatory lymphoproliferative disease with diverse clinical presentations. We report a rare case of iMCD accompanied by severe eosinophilia and diffuse centrilobular pulmonary nodules, which have rarely been previously ...
Li X +6 more
europepmc +2 more sources
Retroperitoneal Castleman disease masquerading as a pancreatic neoplasm: a case report and review of the literature [PDF]
Background Castleman disease (CD) is a rare lymphoproliferative disorder of unclear etiology, often presenting as an asymptomatic, incidentally detected mass.
Sanket Solanki +4 more
doaj +2 more sources
Castleman's Disease: Due to a Rare Intraabdominal Location
Castleman disease (CD) is a rare benign disease with unknown etiology. It is also called angiofollicular lymph node hyperplasia, giant lymph node hyperplasia, lymph node hamartoma, benign giant lymphoma.
Mehmet Cihan Karacaoğlu +4 more
doaj +1 more source
Castleman’s disease (angiofollicular lymphoma, giant lymph node hyperplasia, Castleman’s pseudotumor) is an understudied orphan lymphoproliferative disease with a long period of asymptomatic course and a high risk of malignancy, and variability of its ...
O. M. Mukvich +5 more
doaj +1 more source
Castleman’s disease (angiofollicular lymphoma, giant lymph node hyperplasia, Castleman’s pseudotumor) is an understudied orphan lymphoproliferative disease with a long period of asymptomatic course and a high risk of malignancy, and variability of its ...
V. I. Tsumbaliuk +6 more
doaj +1 more source
POEMS syndrome: Update on diagnosis, risk‐stratification, and management
Abstract Disease Overview POEMS syndrome is a life‐threatening condition due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyradiculoneuropathy, clonal plasma cell disorder, sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley +1 more source
Incidentally detected Castleman disease in a patient with allergic rhinosinu sitis [PDF]
INTRODUCTION Castleman disease was for the first time described in 1956 as a mediastinal tumour mass. Etiology of this disease is still unknown. The disease can be solitary and multicentric or rarely of a mixed type.
Stojšić Jelena +4 more
doaj +1 more source
Microscopic and Immunohistochemistry findings in Castleman Disease. Key Clinical Message Idiopathic Castleman disease transforming into Diffuse Large B‐cell Lymphoma has an aggressive course and can lead to mortality. Hence, early diagnosis and intervention are required.
Ashwini Gupta +9 more
wiley +1 more source
Comprehensive Diagnosis and Management of POEMS Syndrome
Polyneuropathy Organomegaly, Endocrinopathy, Monoclonal protein and Skin changes syndrome is a rare multisystem condition with a range of manifestations which are often overlooked as trivial comorbidities, until their whole triggers the possibility of the diagnosis.
Shirley D'Sa +12 more
wiley +1 more source

